全球血小板市场

预计全球血小板市场规模将从 2025 年的 32 亿美元成长到 2,030 年底的 40 亿美元，预测期内的复合年增长率为 4.6%。

预计北美市场将从2025年的11亿美元成长到2030年底的13亿美元，预测期间的复合年增长率为3.8%。预计欧洲市场将从2025年的9.405亿美元成长到2030年底的12亿美元，预测期间的复合年增长率为4.7%。

本报告调查了全球血小板市场，并提供了市场概况摘要、市场影响因素和市场机会分析、市场规模趋势和预测以及各个细分市场和地区的详细分析。

目录

第一章执行摘要

• 市场展望
• 研究范围
• 市场摘要
• 市场动态与成长要素
• 新兴技术
• 細項分析
• 区域分析
• 结论

第二章 市场概述

• 有关捐血的关键统计数据
• 适合捐血血小板的血型
• 血小板捐献流程
• 波特五力分析
• 宏观经济因素分析
• 经济成长与医疗费用支出
• 世界人口老化
• 政府法规和卫生政策
• 全球疾病负担
• 通货膨胀和捐血服务成本上升
• 美国关税对血小板市场的影响

第三章 市场动态

• 市场动态
• 市场驱动因素
• 增加手术程序
• 加深对捐血重要性的认识
• 加强政府力度
• 慢性血液疾病的盛行率
• 市场限制
• 血小板输注过程中感染风险增加
• 血小板输注费用高昂
• 血小板供应链与物流挑战
• 捐血短缺
• 市场机会
• 再生医学和生物技术中捐血血小板的应用日益广泛
• 新兴市场的需求和不断扩大的医疗基础设施

第四章 监管情况

• 血小板市场的监管洞察

第五章 新兴技术

• 概述
• 新兴技术
• 血小板采集病原体减少技术进展
• 血小板储存系统的开发
• 将人工智慧和自动化融入血液采集和处理

第六章市场区隔分析

• 细分市场
• 市场细分：按血小板类型
• 关键要点
• 单采血小板
• 全血来源的血小板
• 市场区隔：按应用
• 关键要点
• 癌症治疗
• 外科手术
• 治疗慢性疾病
• 创伤
• 血小板减少性疾病（非癌性）
• 血小板功能障碍
• 市场区隔：按最终用户
• 关键要点
• 医院和诊所
• 门诊手术中心
• 血库和输血中心
• 研究实验室
• 癌症治疗中心
• 其他的
• 地理分布
• 市场区隔：按地区
• 关键要点
• 北美洲
• 欧洲
• 亚太地区
• 南美洲
• 中东和非洲

第七章 竞争讯息

• 关键要点
• 竞争格局
• 世界主要组织列表
• 关键发展和策略
• 伙伴关係与合作
• 拓展我们的业务和服务
• 技术开发
• 监管和法律发展

第八章环境、社会与管治（ESG）视角

• ESG：简介
• 血小板市场的永续性
• BCC的结语

第九章 附录

• 调查方法
• 参考
• 简称
• 公司简介
• AABB - ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
• AMERICA'S BLOOD CENTERS
• AUSTRALIAN RED CROSS LIFEBLOOD
• BELGIAN RED CROSS-FLANDERS
• BLOOD BANK OF ALASKA
• BLOOD CENTERS OF AMERICA
• CANADIAN BLOOD SERVICES
• EUROPEAN BLOOD ALLIANCE
• FINNISH RED CROSS BLOOD SERVICE
• INDIAN RED CROSS SOCIETY
• JAPANESE RED CROSS SOCIETY
• ONEBLOOD
• SANBS
• THE AMERICAN NATIONAL RED CROSS
• VITALANT

The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.

The North American market for blood platelets is expected to grow from $1.1 billion in 2025 and is projected to reach $1.3 billion by the end of 2030, at a CAGR of 3.8% during the forecast period of 2025 to 2030.

The European market for blood platelets is expected to grow from $940.5 million in 2025 and is projected to reach $1.2 billion by the end of 2030, at a CAGR of 4.7% during the forecast period of 2025 to 2030.

Report Scope

The report provides an overview of the global blood platelet market and analyzes market trends. It includes global revenue ($ million) for base year 2024, estimates for 2025 and a forecast period through 2030. The market is segmented based on platelet type, application, end user and region. The regions covered in this study include North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, focusing on major countries in these regions.

The report examines the significant trends and challenges that affect the market and blood donation landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report provides an in-depth analysis of the global blood platelets market, with a comprehensive evaluation of the value chain from blood platelets collection to end-use applications. The scope encompasses the activities of blood collection organizations, which are responsible for the voluntary collection of blood donations in each country. These organizations play a critical role in separating, processing and storing platelets from donated blood and ensuring their timely and safe distribution to various healthcare settings.

The market analysis covers the distribution of collected blood platelets to various end users, including hospitals, clinics, ambulatory surgical centers, cancer treatment centers, blood banks and transfusion centers. These facilities use blood platelets for multiple clinical and therapeutic purposes.

The report also examines the operational models of independent and government-funded organizations while also analyzing regulatory frameworks related to platelet donation, safety protocols and distribution standards across the market.

The report concludes with an analysis of the competitive landscape, providing a list of key organizations in the global blood platelet market. It also includes a dedicated section of company profiles that outlines details about leading market enterprises.

Report Includes

• 45 data tables and 53 additional tables
• Overview and analysis of the global market for blood platelets, also known as thrombocytes
• Analyses of global market trends, with revenue data for 2022-2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects for the global blood platelet market, along with a market share analysis by platelet type, application, end-user, and region
• Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, government policies and regulations and the impacts of macroeconomic variables
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• An assessment of the current market environment, innovation and prospects, emerging technologies, new developments, and products in the pipeline
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudes
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of the leading companies, including American National Red Cross, Vitalant, Canadian Blood Services, NHS Blood and Transplant, and Red Cross Society of China

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Introduction
• Key Statistics About Blood Donations
• Blood Types Suitable for Platelet Donations
• Platelet Donation Process
• Porter's Five Forces Analysis
• Threat of New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate)
• Bargaining Power of Buyers (Moderate to High)
• Threat of Substitutes (Very Low)
• Level of Competitiveness (Moderate)
• Macroeconomic Factor Analysis
• Economic Growth and Healthcare Spending
• An Aging Population Worldwide
• Government Regulations and Health Policies
• Global Disease Burden
• Rising Inflation and Cost of Blood Donation Services
• Impact of Ongoing Tariffs Imposed by the U.S. on the Blood Platelet Market

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increased Number of Surgical Procedures
• Better Awareness of the Importance of Blood Donations
• Rising Government Initiatives
• Prevalence of Chronic Blood-Related Disorders
• Market Restraints
• Elevated Risk of Infection in Platelet Transfusion Procedures
• High Cost of Platelet Transfusions
• Challenges in Blood Platelet Supply Chain and Logistics
• Shortage of Blood Donors
• Market Opportunities
• Increased Use of Donated Blood Platelets in Regenerative Medicine and Biotechnology
• Demand from Emerging Markets and Expanding Healthcare Infrastructure

Chapter 4 Regulatory Landscape

• Regulatory Insights into the Blood Platelet Market

Chapter 5 Emerging Technologies

• Overview
• Emerging Technologies
• Advances in Pathogen Reduction Techniques for Platelet Collection
• Developments in Platelet Storage Systems
• Integration of AI and Automation in Blood Collection and Processing

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Platelet Type
• Key Takeaways
• Apheresis-Derived Platelets
• Whole Blood-Derived Platelets
• Market Breakdown by Application
• Key Takeaways
• Cancer Treatment
• Surgical Procedures
• Chronic Disease Treatment
• Traumatic Injury
• Thrombocytopenia (Non-Cancer Related)
• Platelet Function Disorder
• Market Breakdown by End User
• Key Takeaways
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Blood Banks and Transfusion Centers
• Research Laboratories
• Cancer Treatment Centers
• Others
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• List of Leading Organizations Across the Globe
• Key Developments and Strategies
• Partnerships and Collaborations
• Business and Service Expansions
• Technological Developments
• Regulatory and Legal Developments

Chapter 8 Environmental, Social and Governance (ESG) Perspective

• Introduction to ESG
• Sustainability in the Blood Platelet Market
• Concluding Remarks from BCC

Chapter 9 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• AABB - ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
• AMERICA'S BLOOD CENTERS
• AUSTRALIAN RED CROSS LIFEBLOOD
• BELGIAN RED CROSS-FLANDERS
• BLOOD BANK OF ALASKA
• BLOOD CENTERS OF AMERICA
• CANADIAN BLOOD SERVICES
• EUROPEAN BLOOD ALLIANCE
• FINNISH RED CROSS BLOOD SERVICE
• INDIAN RED CROSS SOCIETY
• JAPANESE RED CROSS SOCIETY
• ONEBLOOD
• SANBS
• THE AMERICAN NATIONAL RED CROSS
• VITALANT

List of Tables

• Summary Table : Global Market for Blood Platelets, by Region, Through 2030
• Table 1 : Platelet Use by Patients in the U.S., 2024
• Table 2 : Prevalence of Each Blood Type Among the U.S. Population, by Blood Type, 2024
• Table 3 : Prevalence of Each Blood Type Among the U.S. Population, by Race, 2024
• Table 4 : Tests Used in the U.S. to Screen Donated Blood
• Table 5 : Risk of Acquiring Infectious Disease Through Blood Transfusions
• Table 6 : Comparison Between Whole Blood-Derived and Apheresis-Derived Platelets
• Table 7 : Porter's Five Forces: Rating Scale
• Table 8 : Viral Infections and Their Transmission Risks in Blood Transfusions
• Table 9 : Regulatory Landscape Governing Blood Platelets, by Country
• Table 10 : Global Market for Blood Platelets, by Platelet Type, Through 2030
• Table 11 : Global Market for Apheresis-Derived Platelets, by Region, Through 2030
• Table 12 : Global Market for Whole Blood-Derived Platelets, by Region, Through 2030
• Table 13 : Global Market for Blood Platelets, by Application, Through 2030
• Table 14 : Global Market for Blood Platelets in Cancer Treatment, by Region, Through 2030
• Table 15 : Global Market for Blood Platelets in Surgical Procedures, by Region, Through 2030
• Table 16 : Global Market for Blood Platelets in Chronic Disease Treatment, by Region, Through 2030
• Table 17 : Global Market for Blood Platelets in Traumatic Injuries, by Region, Through 2030
• Table 18 : Global Market for Blood Platelets in Thrombocytopenia (Non-Cancer Related) Treatment, by Region, Through 2030
• Table 19 : Global Market for Blood Platelets in Platelet Function Disorder Treatment, by Region, Through 2030
• Table 20 : Global Market for Blood Platelets, by End User, Through 2030
• Table 21 : Global Market for Blood Platelets in Hospitals and Clinics, by Region, Through 2030
• Table 22 : Global Market for Blood Platelets in Ambulatory Surgical Centers, by Region, Through 2030
• Table 23 : Global Market for Blood Platelets in Blood Banks and Transfusion Centers, by Region, Through 2030
• Table 24 : Global Market for Blood Platelets in Research Laboratories, by Region, Through 2030
• Table 25 : Global Market for Blood Platelets in Cancer Treatment Centers, by Region, Through 2030
• Table 26 : Global Market for Blood Platelets in Other End Users, by Region, Through 2030
• Table 27 : Global Market for Blood Platelets, by Region, Through 2030
• Table 28 : North American Market for Blood Platelets, by Country, Through 2030
• Table 29 : North American Market for Blood Platelets, by Platelet Type, Through 2030
• Table 30 : North American Market for Blood Platelets, by Application, Through 2030
• Table 31 : North American Market for Blood Platelets, by End User, Through 2030
• Table 32 : European Market for Blood Platelets, by Country, Through 2030
• Table 33 : European Market for Blood Platelets, by Platelet Type, Through 2030
• Table 34 : European Market for Blood Platelets, by Application, Through 2030
• Table 35 : European Market for Blood Platelets, by End User, Through 2030
• Table 36 : Asia-Pacific Market for Blood Platelets, by Country, Through 2030
• Table 37 : Asia-Pacific Market for Blood Platelets, by Platelet Type, Through 2030
• Table 38 : Asia-Pacific Market for Blood Platelets, by Application, Through 2030
• Table 39 : Asia-Pacific Market for Blood Platelets, by End User, Through 2030
• Table 40 : South American Market for Blood Platelets, by Country, Through 2030
• Table 41 : South American Market for Blood Platelets, by Platelet Type, Through 2030
• Table 42 : South American Market for Blood Platelets, by Application, Through 2030
• Table 43 : South American Market for Blood Platelets, by End User, Through 2030
• Table 44 : MEA Market for Blood Platelets, by Subregion, Through 2030
• Table 45 : MEA Market for Blood Platelets, by Platelet Type, Through 2030
• Table 46 : MEA Market for Blood Platelets, by Application, Through 2030
• Table 47 : MEA Market for Blood Platelets, by End User, Through 2030
• Table 48 : Key Providers of Blood Platelets, 2024
• Table 49 : Key Partnerships and Collaborations in the Blood Platelet Market, 2024
• Table 50 : Business Expansions in the Blood Platelet Market, 2023-2025
• Table 51 : Technological Developments in the Blood Platelets Market, 2023
• Table 52 : Key Regulatory and Legal Developments in the Blood Platelet Market, 2023
• Table 53 : Sustainability Initiatives by Key Organizations, 2023 and 2024
• Table 54 : Abbreviations Used in the Report
• Table 55 : AABB - Association for the Advancement of Blood & Biotherapies: Company Snapshot
• Table 56 : AABB - Association for the Advancement of Blood & Biotherapies: Product Portfolio
• Table 57 : AABB - Association for the Advancement of Blood & Biotherapies: News/Key Developments, 2023
• Table 58 : America's Blood Centers: Company Snapshot
• Table 59 : America's Blood Centers: Product Portfolio
• Table 60 : Australian Red Cross Lifeblood: Company Snapshot
• Table 61 : Australian Red Cross Lifeblood: Financial Performance, FY 2022 and 2023
• Table 62 : Australian Red Cross Lifeblood: Product Portfolio
• Table 63 : Australian Red Cross Lifeblood: News/Key Developments, 2023 and 2024
• Table 64 : Belgian Red Cross-Flanders: Company Snapshot
• Table 65 : Belgian Red Cross-Flanders: Product Portfolio
• Table 66 : Belgian Red Cross-Flanders: News/Key Developments, 2024
• Table 67 : Blood Bank of Alaska: Company Snapshot
• Table 68 : Blood Bank of Alaska: Product Portfolio
• Table 69 : Blood Centers of America: Company Snapshot
• Table 70 : Blood Centers of America: Product Portfolio
• Table 71 : Blood Centers of America: News/Key Developments, 2023 and 2024
• Table 72 : Canadian Blood Services: Company Snapshot
• Table 73 : Canadian Blood Services: Financial Performance, FY 2022 and 2023
• Table 74 : Canadian Blood Services: Product Portfolio
• Table 75 : Canadian Blood Services: News/Key Developments, 2025
• Table 76 : European Blood Alliance: Company Snapshot
• Table 77 : European Blood Alliance: Product Portfolio
• Table 78 : Finnish Red Cross Blood Service: Company Snapshot
• Table 79 : Finnish Red Cross Blood Service: Financial Performance, FY 2023 and 2024
• Table 80 : Finnish Red Cross Blood Service: Product Portfolio
• Table 81 : Finnish Red Cross Blood Service: News/Key Developments, 2023-2025
• Table 82 : Indian Red Cross Society: Company Snapshot
• Table 83 : Indian Red Cross Society: Product Portfolio
• Table 84 : Japanese Red Cross Society: Company Snapshot
• Table 85 : Japanese Red Cross Society: Product Portfolio
• Table 86 : OneBlood: Company Snapshot
• Table 87 : OneBlood: Product Portfolio
• Table 88 : OneBlood: News/Key Developments, 2023
• Table 89 : SANBS: Company Snapshot
• Table 90 : SANBS: Financial Performance, FY 2022 and 2023
• Table 91 : SANBS: Product Portfolio
• Table 92 : The American National Red Cross: Company Snapshot
• Table 93 : The American National Red Cross: Product Portfolio
• Table 94 : The American National Red Cross: News/Key Developments, 2024-2025
• Table 95 : Vitalant: Company Snapshot
• Table 96 : Vitalant: Product Portfolio
• Table 97 : Vitalant: News/Key Developments, 2023

List of Figures

• Summary Figure : Global Market Shares of Blood Platelets, by Region, 2024
• Figure 1 : Insights and Statistics on Blood Donations
• Figure 2 : Journey of Whole Blood-Derived Platelets
• Figure 3 : Porter's Five Forces Analysis of the Global Blood Platelet Market
• Figure 4 : Snapshot of the Dynamics of the Blood Platelet Market
• Figure 5 : Organ Transplant Procedures Performed, by Organ Type, 2023
• Figure 6 : Emerging Technologies in the Blood Platelet Market
• Figure 7 : Global Market Shares of Blood Platelets, by Platelet Type, 2024
• Figure 8 : Advantages of Apheresis-Derived Platelets
• Figure 9 : Global Market Shares of Apheresis-Derived Platelets, by Region, 2024
• Figure 10 : Global Market Shares of Whole Blood-Derived Platelets, by Region, 2024
• Figure 11 : Global Market Shares of Blood Platelets, by Application, 2024
• Figure 12 : Global Market Shares of Blood Platelets in Cancer Treatment, by Region, 2024
• Figure 13 : Global Market Shares of Blood Platelets in Surgical Procedures, by Region, 2024
• Figure 14 : Global Market Shares of Blood Platelets in Chronic Disease Treatment, by Region, 2024
• Figure 15 : Global Market Shares of Blood Platelets in Traumatic Injuries, by Region, 2024
• Figure 16 : Global Market Shares of Blood Platelets in Thrombocytopenia (Non-Cancer Related) Treatment, by Region, 2030
• Figure 17 : Global Market Shares of Blood Platelets in Platelet Function Disorder Treatment, by Region, 2030
• Figure 18 : Global Market Shares of Blood Platelets, by End User, 2024
• Figure 19 : Global Market Shares of Blood Platelets in Hospitals and Clinics, by Region, 2024
• Figure 20 : Global Market Shares of Blood Platelets in Ambulatory Surgical Centers, by Region, 2024
• Figure 21 : Global Market Shares of Blood Platelets in Blood Banks and Transfusion Centers, by Region, 2024
• Figure 22 : Global Market Shares of Blood Platelets in Research Laboratories, by Region, 2024
• Figure 23 : Global Market Shares of Blood Platelets in Cancer Treatment Centers, by Region, 2024
• Figure 24 : Global Market Shares of Blood Platelets in Other End Users, by Region, 2024
• Figure 25 : Global Market Shares of Blood Platelets, by Region, 2024
• Figure 26 : Snapshot of the ESG Pillars
• Figure 27 : Australian Red Cross Lifeblood: Revenue Shares, by Business Segment, FY 2023
• Figure 28 : Canadian Blood Services: Revenue Shares, by Business Segment, FY 2023
• Figure 29 : Finnish Red Cross Blood Service: Revenue Shares, by Business Segment, FY 2024